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Abstract
 
Wolfram syndrome is a progressive neurodegenerative dis-
order transmitted in an autosomal recessive mode. We re-
port two Wolfram syndrome families harboring multiple
deletions of mitochondrial DNA. The deletions reached per-
centages as high as 85–90% in affected tissues such as the
central nervous system of one patient, while in other tissues
from the same patient and from other members of the fam-
ily, the percentages of deleted mitochondrial DNA genomes
were only 1–10%. Recently, a Wolfram syndrome gene has
been linked to markers on 4p16. In both families linkage be-
tween the disease locus and 4p16 markers gave a maximum
multipoint lod score of 3.79 at 
 
u 5 
 
0 (
 
P 
 
, 
 
0.03) with respect
to 
 
D4S431
 
. In these families, the syndrome was caused by
mutations in this nucleus-encoded gene which deleteriously
interacts with the mitochondrial genome. This is the first
evidence of the implication of both genomes in a recessive
disease. (
 
J. Clin. Invest.
 
 1996. 97:1570–1576.) Key words:
neurodegenerative disease 
 
•
 
 OXPHOS 
 
•
 
 autosomal recessive
inheritance 
 
•
 
 linkage 
 
•
 
 DIDMOAD
 
Introduction
 
Wolfram syndrome (WS)
 
1
 
 (MIM 222300) (1) was described in
1938 by Wolfram and Wagener (2). The most frequent mani-
festations of the syndrome are diabetes insipidus, insulin-
dependent diabetes mellitus (IDDM), bilateral progressive op-
tic atrophy, and deafness. Nonetheless, such manifestations
are not always present, yet the association with other diverse
neurological and psychiatric features, including ataxia, periph-
eral neuropathy, urinary tract atony, dementia, depression,
psychosis, and aggressive behavior, is frequent (3–6). Diagno-
sis is usually established in one or several siblings from unaf-
fected parents with some degree of consanguinity, suggesting
an autosomal recessive mode of transmission (6, 7). Recently,
a Wolfram syndrome gene has been linked to markers on the
short arm of human chromosome 4 (reference 8). Neverthe-
less, the wide spectrum of clinical expression, affecting several
organs and tissues, suggests mitochondrial DNA (mtDNA) in-
volvement, a fact that has already been proven in sporadic
cases (9, 10).
Human mtDNA is maternally transmitted (11) and con-
tains 13 structural genes encoding for subunits of the respira-
tory chain enzyme complexes. The majority of the respiratory
chain enzyme subunits and all the proteins required for the
replication, transcription, and translation of mtDNA are en-
coded in the nucleus. The function of the respiratory chain is
thus regulated by both mitochondrial and nuclear genes. A nu-
clear gene defect that interferes with mtDNA integrity has
been suggested in several families with autosomal dominant
(12) or recessive (13, 14) inheritance associated with multiple
mtDNA deletions. Recently, the first autosomal dominant lo-
cus that predisposes to mtDNA deletions has been localized to
chromosome 10q in families with progressive external ophthal-
moplegia (15).
We report two WS families harboring multiple deletions of
mtDNA in which the disease locus is linked to 4p16. The find-
ings in these families demonstrate that an autosomal locus, lo-
calized to 4p16, predisposes to mtDNA deletions resulting in a
semidominant model of inheritance causing WS when both ho-
mologous chromosomes are affected in one individual. This is
the first direct evidence of the involvement of mitochondrial
and nuclear genomes in an autosomal recessive disorder.
 
Case report.
 
 Two kindreds of Spanish Caucasian origin,
WS1 and WS2 (Fig. 1), were studied.
In family WS1, Wolfram syndrome was diagnosed in four
sisters whose parents were first cousins. All the sisters first pre-
sented with IDDM and dyschromatopsia followed by severe
optic atrophy in their thirties. Later on they developed psychi-
atric abnormalities in the form of anxiety, abnormal behavior,
anterograde amnesia, sphincter disturbances, anosmia, walk-
ing instability, tremor, dysphagia, and swallowing difficulties.
Sisters IV-6 and IV-7 died after food aspiration and IV-4 suf-
fered eight aspirative pneumonias. The autopsy study of IV-6
disclosed severe brain and posterior fossa structure atrophy.
Olfactory, optic, and cochlear nerves appeared demyelinated
and atrophic. Neuron loss was observed in preoptic, paraven-
tricular, and thalamic nuclei, dorsal nucleus of the vagus, am-
biguous nucleus, and olivary and pontine nuclei. There was
Purkinje cell loss in cerebellum and reduced motor neuron
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number in spinal cord. The periventricular white matter was
demyelinated.
The patient in the nonconsanguineous WS2 family was a
27-yr-old male. At 8 yr of age, he developed IDDM. When he
was 16, bilateral atrophy of optic nerves and neurosensorial
deafness for high frequencies were detected. 2 yr later, the vi-
sual loss was almost complete and he developed diabetes insip-
idus when he was 23 yr old.
 
Methods
 
Biochemical studies.
 
 Lymphocytes from all members of family WS2
were isolated from 10 ml blood on a Ficoll cushion. The polaro-
graphic studies were performed at 30
 
8
 
C as previously described (16).
Assays of intact cell respiration and mitochondrial substrate (glutamate,
pyruvate-malate, succinate, and glycerol-3-phosphate) oxidation by
detergent-permeabilized cells were performed. Enzymatic assays of
NADH cytochrome 
 
c
 
 reductase, cytochrome 
 
c
 
 oxidase, and succinate
cytochrome 
 
c
 
 reductase activities were carried out spectrophotomet-
rically (UVIKON 860; Kontron AS, Zurich, Switzerland) as de-
scribed elsewhere (16). 11 healthy individuals with ages ranging from
17 to 49 yr were taken as controls.
 
mtDNA studies.
 
 Total DNA was extracted from blood samples of
members of both families and from skeletal muscle, liver, and several
areas of the brain from the autopsied WS1 patient IV6. mtDNA was
linearized by digestion with PvuII restriction endonuclease (cut in nu-
cleotide [nt] 2650) (Boehringer Mannheim Corp., Indianapolis, IN),
separated through 0.8% agarose gel electrophoresis, blotted onto ny-
lon membrane (Biodyne A; Pall Biosupport Corp., Glen Cove, NY),
hybridized with whole human mtDNA labeled with [
 
32
 
P]
 
a
 
dCTP
(Amersham Corp., Arlington Heights, IL), and autoradiographed.
The filter was subsequently hybridized with an mtDNA probe span-
ning from nucleotide 459 to 3334, and then with an mtDNA probe
spanning from nucleotide 10122 to 11587 (PR2). mtDNA was also lin-
earized by digestion with SnaBI restriction endonuclease (cut in nt
10736) (Boehringer Mannheim Corp.) (Fig. 2) and subsequently hy-
bridized with probes PR1 (nt 4214–5791) and PR2 (Fig. 2). Several
pairs of primers (e.g., L820 [nt 8200–8220] and H1619 [nt 16210–
16190], PM1 [8335–8355], and PM2 [14110–13990]) (Fig. 2) were used
to PCR amplify regions of mtDNA as previously described (13, 17).
The fragments containing the deletion break points were run on
5–8% polyacrylamide gels. The most represented bands were cut out
from the gel, reamplified with the same primers, and purified using
Qiaquick Spin PCR purification Kit (QIAGEN Inc., Chatsworth,
CA). Direct automatic sequencing was performed with 3.5 pmol of
sequencing primers using a Taq Dye Deoxy™ Terminator Sequenc-
ing kit (No. 401113; Applied Biosystems, Foster City, CA) according
to manufacturer’s recommendations. Sequencing primers were those
used in the original PCR amplifications. Data analyses were per-
formed with the 373A sequencing software from ABI Advanced Bio-
technologies, Inc. (Columbia, MD). To quantify the relative propor-
tion of normal and deleted mtDNA, Southern autoradiographs were
scanned, correcting for the background, with a Préférence/DVS-1500
densitometer (Sebia, Paris, France). When the deletions were not de-
tected by Southern blot, the relative proportion of deleted versus to-
tal mtDNA was estimated using a semiquantitative PCR-based
method modified after DiDonato et al. (18). The number of amplifi-
cation cycles was chosen to take into account the PCR exponential
phase. Total DNA was diluted to 1 
 
m
 
g/
 
m
 
l in 1 
 
3 
 
10 mM TRIS-HCl/1
mM EDTA (pH 8.0). Serial 10-fold dilutions were made down to 100
pg/
 
m
 
l. For each dilution, a differential PCR amplification was ob-
tained using two pairs of primers. The primers PR2
 
1
 
 (nt 10122–10143)
and H
 
Arg
 
 (nt 10522–10504) were used to amplify a 382-bp fragment,
internal to the deletions sequenced in patients; the second pair of
primers (L
 
Leu-1
 
 -nt 3164–3183- and H
 
Leu-1 
 
-nt 3353–3334) were used to
amplify a 170-bp fragment external to the deletion. The 170-bp frag-
ment corresponds to the amplification product generated from the to-
tal mtDNA template (TT) contained in each sample. The 382-bp
fragment was considered as the nondeleted mtDNA (NDT). 8 
 
m
 
l of
the PCR amplifications was run in a 0.8% agarose gel and ethidium
bromide stained, and the fragments were visualized under ultraviolet
light. Densitometric analyses were performed with a scanner (ScanJet
IIcx; Hewlett-Packard Co., Palo Alto, CA) and with a densitometer
(Préférence/DVS 1500; Sebia). After correction for the length of the
fragments, the series of densitometrical values corresponding to TT
and NDT amplifications were plotted as a function of the logarithm
of template dilutions and a linear regression analysis was performed
Figure 1. Pedigree of families 
WS1 and WS2. The individuals’ 
identification number is shown 
above and left of the symbol. 
Dashed symbols represent clini-
cally asymptomatic patients with 
mtDNA deletions, filled symbols 
represent clinically affected pa-
tients with mtDNA deletions, 
and open symbols represent nor-
mal individuals without mtDNA 
deletions. Vertically half-filled 
symbols identify patients whose 
only clinical problem was diabe-
tes mellitus, and horizontally 
half-filled symbols identify pa-
tients with neurosensory hearing 
loss. Numbers under symbols 
represent the haplotypes for 
markers D4S412, D4S431, and 
D4S394.
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for the two series. The coefficient of linear correlation was, in all
cases, consistently 
 
. 
 
0.97. The percentage of the deleted mtDNA ver-
sus total mtDNA was obtained as described elsewhere (18).
 
Genotyping studies. 
 
To analyze microsatellites 
 
D4S412
 
, 
 
D4S431
 
,
and 
 
D4S394
 
, the dinucleotide repeat alleles were PCR-amplified with
primers obtained from the Human Genome Research Center (Evry,
France) in a final reaction volume of 25 
 
m
 
l. The reaction contained
100 ng of DNA, 1 pmol of the [
 
33
 
P]
 
g
 
dATP end labeled forward
primer, 10 pmol of the reverse primer, 0.5 U of 
 
Taq
 
 polymerase (Boeh-
ringer Mannheim Corp.), 200 
 
m
 
M of each of the four deoxynucle-
otides, and 
 
Taq
 
 polymerase incubation buffer (Boehringer Mann-
heim Corp.). Samples were amplified in a thermocycler (model 9600;
Perkin-Elmer Corp., Norwalk, CT) for 35 cycles of 25 s at 95
 
8
 
C, 25 s
at 56
 
8
 
C, and 25 s at 74
 
8
 
C, followed by a 5-min final extension at 74
 
8
 
C.
16 
 
m
 
l of dye containing 95% formamide was added to the reaction, the
samples were then denatured at 95
 
8
 
C for 1–2 min and ice-cooled
immediately. Amplification products were then electrophoresed in
6% denaturing polyacrylamide gels at 1,500 V. Gels were transferred,
vacuum dried, and exposed to radiographic film. Allele sizes were
determined from a CEPH control individual of known genotype
(1347-02).
 
Linkage studies.
 
 We performed linkage studies using the lod score
method (19). To facilitate the calculation, we used the programs
MLINK, ILINK, and LINKMAP from FASTLINK SOFTWARE
V2.2 (20). We used three 4p16 markers (
 
D4S412
 
, 
 
D4S431
 
, and
 
D4S394
 
) which define a region from which linkage to WS locus has
been demonstrated previously (8). The deleterious allele frequency
was set at 0.01 and all marker alleles were considered to be equally
frequent. Varying the allele frequencies did not significantly alter the
lod scores, due to the small number of untyped individuals in the ped-
igrees. It was necessary, due to computational constraints, to down-
code alleles to a maximum of three for 
 
D4S412
 
, five for 
 
D4S431
 
, and
four for 
 
D4S394
 
. In the multipoint analysis a fixed distance of 6 cM
between each of the three loci was considered in accordance with the
reported data (21). We used computer simulation methods to cal-
culate the signification (
 
P
 
 value) associated with the multipoint
lod score (22, 23). All the programs were run in a UNIX SPARC
SOLARIS 2.4 computer.
 
Results
 
Enzymological studies.
 
 The oxidative phosphorylation path-
way in lymphocytes from the WS patient of family WS2 was
studied. When pyruvate, glutamate, or succinate was used as
substrate for mitochondrial oxidation in detergent-permeabi-
lized cells, a significant functional deficiency was demon-
strated (36, 45, and 24%, respectively). The ratios between the
different substrates were normal. Enzymatic assays showed a
decrease of 22% for NADH cytochrome 
 
c 
 
reductase, 29% for
cytochrome 
 
c
 
 oxidase, and 9% for succinate cytochrome 
 
c
 
 re-
ductase activities. His parents, brother, and sister showed nor-
mal mitochondrial function.
 
mtDNA studies in family WS1.
 
 Southern blot analysis of
mtDNA probed with the whole mtDNA demonstrated multi-
ple deletions in all the areas of the central nervous system
(CNS) analyzed from the autopsy study of patient IV-6. The
deletions ranged from 1.5 to 10 kb (Fig. 3 
 
a
 
). When the filter
was hybridized with PR2, a probe internal to the deletions, no
abnormal bands were found (Fig. 3 
 
b
 
). Liver and muscle from
IV-6 patient as well as lymphocytes from the remaining mem-
bers of the family examined did not reveal any abnormal band.
To demonstrate the nature of the mtDNA rearrangements
found in the brain of the patient, we digested mtDNA with
SnaBI, an enzyme that cuts at nt 10736, internal to the rear-
rangements. When we hybridized with PR1, a probe external
to the deletions, two bands were found: one of 16.5 kb corre-
sponding to the wild-type band and some comigrating undi-
gested rearranged molecules, and another of 10 kb corre-
sponding to the other undigested rearranged molecules (Fig. 3
 
c
 
). A normal pattern after hybridization with PR2 indicates
that rearrangements were deletions and not duplications. The
Figure 2. Schematic representa-
tion of the mitochondrial ge-
nome. The probes PR1 and PR2 
and the restriction sites of the 
enzymes PvuII and SnaBI are 
placed. At the bottom, the ar-
rows represent some of the 
primer pair used in the PCR 
analyses and the location of the 
sequenced deletions for the fam-
ilies: a, WS1; b, WS2.
Figure 3. Southern blot analysis of tissues obtained from patient IV-6 
of family WS1. (a) PvuII digestion probed with whole mtDNA; (b) 
SnaBI digestion hybridized with a probe spanning from nt 10122 to 
11587 (PR2); (c) SnaBI digestion hybridized with a probe spanning 
from nt 4214 to 5791 (PR1). C, control; Li, liver; M, skeletal muscle; 
F, frontal lobe; T, temporal lobe; Sb, white matter; Ca, caudate.
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fact that some undigested mtDNA molecules appear to have
the same size in the SnaBI digestion is probably due to the sec-
ondary structure adopted by the mtDNA molecules with dif-
ferent deletions allowing them to comigrate. PCR analyses
with primers distributed along the mtDNA genome disclosed
the presence of several fragments confirming the existence of
multiple deletions. For example, PCR analyses with primers
L820 and H1619 revealed several fragments ranging from 200
to 500 bp approximately, corresponding to multiple deletions
of 7.5–7.8 kb (Fig. 4). These fragments were found in lympho-
cytes of the family members with dashed symbols in the pedi-
gree (Fig. 1) and in all tissues studied from patient IV-6. The
results were reproduced with nested PCRs. The deletions
found by PCR were similar in size, but not identical, in the dif-
ferent members of the family and different tissues of patient
IV-6. The proportion of deleted molecules ranged between 85
and 90% in affected tissues such as the CNS from patient IV-6
(Table I), while in other tissues (liver and skeletal muscle)
from the same patient, as well as lymphocytes from other
members of the family, the proportion ranged from 1 to 10%.
Several bands detected by Southern blot and PCR analysis in
brain of patient IV-6 were reamplified and sequenced. Dele-
tions were flanked by perfect short direct repeats of 5–9 bp
(Figs. 2 and 5).
 
mtDNA studies in family WS2.
 
 PvuII Southern blot analysis
Figure 4. PCR analyses of mtDNA from family WS1 with primers 
L820 (nt 8200–8220) and H1619 (nt 16210–16190). (A and B) Analy-
ses of all the members of the family; (C) analyses of different tissues 
from patient IV-6. PCR analyses revealed several fragments ranging 
from 200 to 500 bp approximately, corresponding to multiple dele-
tions of 7.5–7.8 kb. The numbers are the same as those in the pedi-
gree of family WS1 (Fig. 1). L, lymphocytes; Li, liver; M1, marker; M, 
skeletal muscle; F, frontal lobe; H, hippocampus; T, temporal lobe; 
Sb, white matter; W, control without DNA.
 
Table I. Percentage of Deleted mtDNA in Different Tissues 
from Patient IV-6 of the WSI Family
 
Tissue Percentage of deleted mtDNA
 
Liver
 
z
 
 5
Skeletal muscle
 
z
 
 5
Lymphocytes
 
z
 
 5
Brain areas
Frontal 90
Caudate 85
White matter 87
Temporal 86
Putamen 91
Figure 5. Sequence of the mtDNA deletions found in families WS1 
and WS2. Nucleotide numbering is in accordance with the Cambridge 
human mtDNA sequence of the L strand, reading 59 to 39 (reference 
31). Deleted fragment is indicated in parentheses. Direct repeats are 
bold. On the right hand side the nucleotides 59 and 39 limiting the de-
letions (the length of the deletion is in parentheses) are shown. The 
genes involved in the break point of any deletion are shown above 
the 59 and 39 ends of the sequences. ND5, NADH dehydrogenase 
subunit 5 gene; ATPase 6, ATPase subunit 6 gene; ATPase 8, ATPase 
subunit 8 gene; Dloop, deplacement loop noncoding region; COII, 
cytochrome c oxidase subunit II gene; tRNAThre, threonine tRNA 
gene.
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of mtDNA from lymphocytes hybridized with the whole
mtDNA probe disclosed abnormal bands of 7–14 kb corre-
sponding to multiple deletions of 2.5–9.5 kb in the patient (II-3)
and his sister (II-2) (Fig. 6) accounting for 55 and 16% of
whole mtDNA molecules, respectively. Hybridization with
PR2 disclosed a normal pattern in all members. PCR analyses
with primers distributed along the mtDNA genome disclosed
the presence of several fragments confirming the existence of
multiple deletions. For example, PCR analysis using primers
PM1 and PM2 showed in all individuals, except II-1, several
fragments ranging from 400 to 1,800 bp approximately, repre-
senting multiple deletions from 3.8 to 5.2 kb that were similar
in size, but not identical, in the different members of the family
(Fig. 7). The results were confirmed with nested PCRs. Several
bands detected by Southern blot and PCR analysis in lympho-
cytes of patient II-3 were reamplified and sequenced. Dele-
tions were flanked by perfect short direct repeats of 5–6 bp
(Figs. 2 and 5).
 
Linkage between Wolfram syndrome and markers on 4p16.
 
Wolfram syndrome is considered to be transmitted in an auto-
somal recessive way. In accordance with the presence of
mtDNA rearrangements and disease signs and symptoms, we
hypothesized a model with three different phenotypes which
could be explained by a nuclear biallelic gene (
 
1
 
/D) in an au-
tosomal semidominant form of transmission. Genotype 
 
1
 
/D
would produce mtDNA deletions but no disease manifesta-
tions, D/D would produce mtDNA deletions and disease man-
ifestations, and 1/1 would produce no deletions and a healthy
individual (wild-type). This mode of inheritance preserves the
classical autosomal recessive model of transmission for the dis-
ease and allows the inclusion of mtDNA deletions as a part of
Wolfram syndrome in our families. We performed linkage
analysis using three 4p16 markers (D4S412, D4S431, and
D4S394) with 6 cM of genetic distance between them (8). In
the two-point analyses (disease locus versus loci markers) the
highest lod score corresponded to D4S394 with Zmax 5 2.67 at
u 5 0. We found linkage between the disease locus and the an-
alyzed 4p16 markers with a maximum multipoint lod score of
3.79 at u 5 0 with respect to marker D4S431 (P , 0.03). This
demonstrated linkage between the WS trait locus in these fam-
ilies and the region defined by the markers used in the multi-
point analysis.
Discussion
This study demonstrates the presence of familial multiple
mtDNA deletions in two pedigrees with autosomal recessive
Wolfram syndrome as well as linkage to the 4p16 region as de-
fined by markers D4S431 and D4S394. Our results are direct
evidence of the implication of both nuclear and mitochondrial
genomes, such that Wolfram syndrome is the first autosomal
recessive disorder in which a dual involvement is demon-
strated.
Linkage of the gene for WS to the 4p16 region had been
shown previously (8), but mtDNA analysis in the linked fami-
lies was not performed or reported. The usual finding in famil-
ial disorders associated with mtDNA rearrangements is the
presence of multiple deletions in skeletal muscle (12, 14, 24) or
lymphocytes (24, 25). In the WS families reported here, the
mtDNA deletions appeared in different tissues and propor-
tions. In family WS1, the deletions were present in lympho-
cytes at a percentage ranging from 1 to 10%. In patient IV-6,
the only patient in whom other tissues could be studied, the
percentage of deleted molecules in muscle and liver was simi-
lar to that found in lymphocytes, but in CNS, the tissue pre-
dominantly affected from a clinical point of view, the deleted
molecules reached a proportion of 85–90% (Table I). Respira-
tory chain diseases considered to be due to mtDNA rearrange-
ments usually present a proportion of deleted molecules of
. 50%. Thus, the figure of 85–90% found in the CNS of pa-
tient IV-6 has to be considered the cause, at least in part, of the
expression of WS. In family WS2 a high proportion of deleted
molecules (55%) was found in the lymphocytes of the patient
and, in a lower proportion, in their asymptomatic relatives.
The relevance of such deletions was further supported by the
demonstration of a generalized deficiency of respiratory en-
zyme activities in patient II-3.
A percentage , 1% of mtDNA-deleted molecules has
been found in normal individuals with increasing age, basically
in tissues such as muscle, heart, and CNS (26, 27) and has been
suggested to be an epiphenomenon related to lifetime oxida-
tive damage. In our families, percentages ranging from 1 to
10% of deleted mtDNA molecules in both old and young
members of the pedigrees and their tissue distribution suggest
that factors other than age have to be considered in the origin
of multiple mtDNA deletions. These rearrangements, if present
in appropriate proportions in target tissues, have to be consid-
ered not just as a phenotypic WS marker with no clinical rele-
vance but as an important factor in modulating the expression
of the disease.
A disruption in communication between nuclear and mito-
chondrial genomes had already been demonstrated in autoso-
mal dominant disorders (12) and proposed in cases of autoso-
mal recessive transmission (13, 14), but until now this has not
been proven. The presence of mtDNA deletions in both pater-
nal and maternal lineages excludes maternal transmission and
Figure 6. PvuII Southern blot analysis of lymphocytes from family 
WS2 probed with whole mtDNA. The numbers are the same as those 
in the pedigree of family WS2 (Fig. 1). C1 and C2 are controls.
Figure 7. PCR analyses 
of mtDNA from lym-
phocytes from mem-
bers of family WS2 
with primers PM1 (nt 
8335–8355) and PM2 
(nt 14010–13990). The 
numbers are the same 
as those in the pedigree 
of family WS2 (Fig. 1). 
L, lymphocytes; M, 
marker.
Nuclear-driven Multiple Mitochondrial DNA Deletions in Wolfram Syndrome 1575
also excludes it being a primary mtDNA disorder. On the con-
trary, it indicates the presence of a nuclear-encoded factor pre-
disposing to multiple mtDNA deletions transmitted as a Men-
delian trait. The expression and penetrance of the WS gene
could also be due to its pleiotropic effects or to epigenic fac-
tors, either mitochondrial or nuclear in origin.
We propose a model of inheritance for WS based on a
semidominant mode of transmission with the presence of
mtDNA deletions in heterozygous individuals at a lower pro-
portion than in homozygotes, this low proportion probably not
contributing to the clinical phenotype. The incomplete pheno-
type present in many heterozygous individuals such as deaf-
ness and diabetes mellitus (III-1 and III-2 in family WS1) and
psychiatric illness (28) would be due to some degree of pene-
trance of a single copy of the deleterious gene. We found a
maximum multipoint lod score of Z 5 3.79 at u 5 0 from
D4S431 locus. The significance value is P , 0.03, which dem-
onstrates linkage between the trait locus and the region de-
fined by the loci markers used in the analysis. As it is not possi-
ble to directly infer the associated significance value for lod
scores in a multipoint analysis, we obtained it through simula-
tion studies (22, 23). The trait locus includes the mitochondrial
rearrangements as part of the disease phenotype, and our link-
age results demonstrate that this inclusion is not arbitrary, con-
cluding that some WS families show mitochondrial involve-
ment as part of their syndromic manifestations. This conclusion
invites discussion on important physiopathological aspects in
order to totally explain the phenotype of the syndrome and
places the attention on the role of the mitochondria in neuro-
degenerative disorders. On the other hand, the incidence of
the disease has been estimated at 1 out of 10,000 live-born in-
dividuals (8). This accounts for a carrier frequency of H 5 1/100
according to the Hardy-Weinberg equilibrium. The high fre-
quency of this allele in the general population may account for
some cases of common disorders such as diabetes mellitus,
deafness, or psychiatric disturbances.
The findings reported in these two WS families point out
the implication of a gene related to mitochondrial biogenesis.
The three housekeeping genes involved in this process hith-
erto described (a) the gene encoding for the RNA component
of mitochondrial RNA processing protein (29); (b) the mito-
chondrial transcription factor A; and (c) the mitochondrial sin-
gle-strand DNA-binding protein (30) have been mapped to
chromosomes other than 4 and thus can be excluded as candi-
date genes. Genes encoding factors implicated in mtDNA
turnover or in oxidative metabolism regulation could also be
considered as possible candidate genes. How the 4p16 WS lo-
cus predisposes to mtDNA rearrangements is still an open
question.
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